omprise a substantial portion of total health¬ care expenditures. Lung volume reduction surgery (LVRS) has emerged recently as a treatment modal¬ ity for patients with advanced emphysema. LVRS has the potential to improve lung function, reduce dys¬ pnea, and improve quality of life in selected individ¬ uals with emphysema.1-3 Selection criteria for LVRS are presently evolving and variability among medical centers has been observed. 4 Considerable debate has ensued about the proper role of LVRS in the management of emphysema. [5] [6] If LVRS becomes an established option for the treatment of emphysema, it will be necessary to assess the financial implications to the health-care system. Given The eight patients whose hospital costs were > $50,000 were compared with the remaining pa¬ tients in the sample. As 
